Harvard Health Letter

News briefs: Bisphosphonates may help men with osteoporosis

The commonly used bone-strengthening drugs called bisphosphonates may provide the same level of benefit for men as they do for women. It appears the drug zoledronic acid (Reclast) significantly reduced spinal fractures in men with osteoporosis.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In